PPT-NAFLD risk factors Obesity

Diabetes Hypertension HDL lt 1 mmol L Triglycerides gt 17 mmol L Suspicion of NAFLD Remember normal LFTs do not rule out liver disease Exclude significant alcohol misuse intermediate or high risk group in the alcohol related liver disease pathway before diagnosing NAFLD via this pathway. By Edward Harris. Dept. of Biochemistry. Liver structure overview. Sasse et al. 1992. Hepatocyte. Endothelial cell. Kupffer cell. Stellate cell. Space of Disse. How to purify SEC, HC, HSC. Liver . Perfusion. NAFLD. Hepatic . Manifestation of Metabolic Syndrome. a. NAFLD (cont). Hepatic . Manifestation of Metabolic Syndrome. a. NAFLD/NASH Closely Associated With Visceral Obesity, Insulin Resistance. AASLD. Masi. . Khaja. , M.D. Objectives . Epidemiology. Natural History. Clinical Presentation. Pathogenesis. Approach to Diagnosis. Treatment. What is NAFLD?. Nonalcoholic Fatty Liver Disease. [NAFLD]. STEATOSIS. Katharine K. Roberts, MD. UCSD Transplant Hepatology Fellow. 9/30/2017. Disclosures. None. Objectives. Define NAFLD and its subtypes. Differentiate between simple steatosis and steatohepatitis. Discuss the pathogenesis of . Disease. . s_khalilzadeh. A Novel. Cardiometabolic Risk Factor for Type 2 Diabetes. NAFLD and T2DM. NAFLD is closely associated with features of the metabolic. syndrome and is regarded as the hepatic manifestation. adults. Dr.mousavi. -Abadan-. Khordad. 1397 . DEFINITIONS — Patients with nonalcoholic fatty liver disease (NAFLD) . have hepatic . steatosis. , . with or without . inflammation and fibrosis. . In addition, . New Advances for NAFLD/NASH NAFLD: A Spectrum of Disease Who Is at Risk for NAFLD and NASH? Prevalence of NAFLD in Europe Prevalence of NAFLD and NASH Predicted to Increase in Europe What Is the Burden of NAFLD in Europe? Moderator. Kris V. Kowdley, MD . Director . Liver Institute Northwest . Clinical Professor. Elson S. Floyd College of Medicine. Washington State University. Seattle, Washington . Overview of Discussion. Hepatologist. East & North Hertfordshire NHS Trust. Royal Free London NHS Foundation Trust. ELF Research Group. University College London. Liver disease. Scale of the problem. Liver disease is the 5. Scott Gee, MD. Kaiser Permanente. February 18, 2010. French Camp, CA . Disclosure. Pediatric Skill Sets for Improved Care. I have no relevant financial relationship with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in this CME activity.”. William Alazawi MA(. Cantab. ) PhD MRCP. Senior Lecturer and Consultant in . Hepatology. Queen Mary, University of London. Does Liver Disease Matter?. Mortality in England & Wales. Liver-related mortality in under 65s. 269 flammation, Cardiovascular disease, Endothelium.IntroductionNAFLD with obesity, type 2 diabetes andNAFLD is still not clear, even if the insulin. In particular, a decreased sensi-. Moreover, a lar Rohit . Pai. MD, FRCPC. Gastroenterology and Hepatology. Island Health and Pacific Digestive Health. Clinical Assistant Professor, UBC. Liver Care Clinic, Royal . Jubillee. Hospital. Disclosures. Research: Intercept. Obesity. is a . medical condition. in which excess . body fat. has accumulated to the extent that it may have a negative effect on health, leading to reduced . life expectancy. and/or increased health problems..